KRAS and cancer: It is also possible that the effects of KRAS may be insufficient to drive a full blown VTE, or hypercoagulability and require additional cooperating processes (87) A better understanding of such cooperating factors could be crucial for more effective management of VTE in PDAC, or other KRAS driven cancers.